Endocannabinoids such as AEA and CB2 receptors and enzymes such as fatty acid amide hydrolase (FAAH) influence retrograde signalling (observed in Alzheimer’s disease) in the brain. The gene discussed is FAAH; the disease is early-onset autosomal dominant Alzheimer disease.